A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis
Public ClinicalTrials.gov record NCT02016885. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Vehicle Controlled, Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis
Study identification
- NCT ID
- NCT02016885
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Journey Medical Corporation
- Industry
- Enrollment
- 198 participants
Conditions and interventions
Conditions
Interventions
- glycopyrrolate, 1.0% Drug
- glycopyrrolate, 2.0% Drug
- glycopyrrolate, 3.0% Drug
- glycopyrrolate, 4.0% Drug
- Vehicle Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2013
- Primary completion
- Aug 31, 2014
- Completion
- Aug 31, 2014
- Last update posted
- Aug 24, 2021
2013 – 2014
United States locations
- U.S. sites
- 21
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Burke Pharmaceutical Research | Hot Springs | Arkansas | 71913 | — |
| Gary M. Petrus, MD, PA | Little Rock | Arkansas | 72202 | — |
| California Dermatology & Clinical Research Institute | Encinitas | California | 92024 | — |
| Center For Dermatology Clinical Research | Fremont | California | 94538 | — |
| Florida Academic Dermatology Center | Miami | Florida | 33136 | — |
| Kenneth R. Beer, MD, PA | West Palm Beach | Florida | 33401 | — |
| Shideler Clinical Research Center | Carmel | Indiana | 46032 | — |
| Cypress Medical Research Center, LLC | Wichita | Kansas | 67226 | — |
| Minnesota Clinical Study Center | Fridley | Minnesota | 55432 | — |
| Saint Louis University Dermatology | St Louis | Missouri | 63122 | — |
| Skin Specialists, PC | Omaha | Nebraska | 68144 | — |
| The Dermatology Group, PC | Verona | New Jersey | 07044 | — |
| Oregon Medical Research Center | Portland | Oregon | 97223 | — |
| J&S Studies, Inc. | College Station | Texas | 77845 | — |
| Clinical Trials of Texas, Inc. | San Antonio | Texas | 78229 | — |
| Dermatology Research Center, Inc. | Salt Lake City | Utah | 84117 | — |
| Virginia Clinical Research, Inc. | Norfolk | Virginia | 23507 | — |
| Westend Dermatology Associates | Richmond | Virginia | 23233 | — |
| Dermatology Associates | Seattle | Washington | 98101 | — |
| Women's Clinical Research Center | Seattle | Washington | 98105 | — |
| Premier Clinical Research | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02016885, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 24, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02016885 live on ClinicalTrials.gov.